Latest Insider Transactions at Akebia Therapeutics, Inc. (AKBA)
This section provides a real-time view of insider transactions for Akebia Therapeutics, Inc. (AKBA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Akebia Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Akebia Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2023
|
David A Spellman SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
7,539
-1.44%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
Michel Dahan SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,090
-3.36%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,539
-1.22%
|
$0
$0.81 P/Share
|
|
Feb 27
2023
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
38,632
-2.27%
|
$0
$0.81 P/Share
|
|
Jan 31
2023
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,200
+24.17%
|
-
|
|
Jan 31
2023
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
196,200
+27.21%
|
-
|
|
Jan 31
2023
|
John P. Butler CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
293,125
+14.71%
|
-
|
|
Aug 31
2022
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,147
-0.27%
|
$0
$0.36 P/Share
|
|
Jun 08
2022
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+37.84%
|
-
|
|
Jun 08
2022
|
Adrian Adams |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+11.56%
|
-
|
|
Jun 08
2022
|
Ron Frieson |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+50.0%
|
-
|
|
Jun 08
2022
|
Steven C Gilman |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+19.34%
|
-
|
|
Jun 08
2022
|
Michael W Rogers |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+17.18%
|
-
|
|
Jun 08
2022
|
Cynthia Smith |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+17.36%
|
-
|
|
Jun 08
2022
|
Myles Wolf |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+26.66%
|
-
|
|
Jun 08
2022
|
Leanne M Zumwalt |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+50.0%
|
-
|
|
Jun 03
2022
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
4,567
-9.52%
|
$0
$0.36 P/Share
|
|
May 12
2022
|
Violetta Cotreau SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+40.55%
|
-
|
|
May 12
2022
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+32.38%
|
-
|
|
Mar 01
2022
|
David A Spellman SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
803
-0.62%
|
$1,606
$2.17 P/Share
|
|
Mar 01
2022
|
Nicole R. Hadas SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
14,507
-1.55%
|
$29,014
$2.17 P/Share
|
|
Mar 01
2022
|
Dell Faulkingham SVP, CCO |
SELL
Open market or private sale
|
Direct |
6,705
-1.87%
|
$13,410
$2.17 P/Share
|
|
Mar 01
2022
|
Michel Dahan SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14,978
-1.64%
|
$29,956
$2.17 P/Share
|
|
Mar 01
2022
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,656
-1.72%
|
$15,312
$2.17 P/Share
|
|
Mar 01
2022
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
53,973
-1.25%
|
$107,946
$2.17 P/Share
|
|
Feb 28
2022
|
David A Spellman SVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+31.68%
|
-
|
|
Feb 28
2022
|
David A Spellman SVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
7,400
-9.64%
|
$14,800
$2.15 P/Share
|
|
Feb 28
2022
|
Nicole R. Hadas SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.67%
|
-
|
|
Feb 28
2022
|
Nicole R. Hadas SVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,555
-2.41%
|
$13,110
$2.15 P/Share
|
|
Feb 28
2022
|
Dell Faulkingham SVP, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+21.69%
|
-
|
|
Feb 28
2022
|
Dell Faulkingham SVP, CCO |
SELL
Open market or private sale
|
Direct |
6,479
-4.73%
|
$12,958
$2.15 P/Share
|
|
Feb 28
2022
|
Michel Dahan SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.93%
|
-
|
|
Feb 28
2022
|
Michel Dahan SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,555
-2.47%
|
$13,110
$2.15 P/Share
|
|
Feb 28
2022
|
Violetta Cotreau SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,833
+36.86%
|
-
|
|
Feb 28
2022
|
Violetta Cotreau SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,946
-11.93%
|
$7,892
$2.15 P/Share
|
|
Feb 28
2022
|
Steven Keith Burke SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+21.14%
|
-
|
|
Feb 28
2022
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,400
-4.32%
|
$14,800
$2.15 P/Share
|
|
Feb 28
2022
|
John P. Butler CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
293,125
+16.75%
|
-
|
|
Feb 28
2022
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
25,053
-2.11%
|
$50,106
$2.15 P/Share
|
|
Jan 03
2022
|
Violetta Cotreau SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,833
-14.99%
|
$11,666
$2.29 P/Share
|
|
Aug 31
2021
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,042
-0.6%
|
$2,084
$2.83 P/Share
|
|
Jun 07
2021
|
Steven C Gilman |
SELL
Open market or private sale
|
Direct |
4,567
-8.69%
|
$13,701
$3.32 P/Share
|
|
Jun 02
2021
|
Steven C Gilman |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+20.67%
|
-
|
|
Jun 02
2021
|
Michael Thomas Heffernan |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+22.0%
|
-
|
|
Jun 02
2021
|
Adrian Adams |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+13.07%
|
-
|
|
Jun 02
2021
|
Michael W Rogers |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+20.75%
|
-
|
|
Jun 02
2021
|
Cynthia Smith |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+21.0%
|
-
|
|
Jun 02
2021
|
Myles Wolf |
BUY
Grant, award, or other acquisition
|
Direct |
13,700
+36.36%
|
-
|
|
Apr 01
2021
|
Steven Keith Burke SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,081
-0.63%
|
$3,243
$3.4 P/Share
|
|
Apr 01
2021
|
John P. Butler CEO and President |
SELL
Open market or private sale
|
Direct |
4,109
-0.36%
|
$12,327
$3.4 P/Share
|